WELLTOWER INC.
WELLTOWER INC. Q3 FY2026 earnings call
October 27, 2026 · fiscal period ended 2026-09
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2026-10-27
Management highlights
- Strategic Shift to Pricing Power: As occupancy rates cross 90%, the primary driver of revenue growth is shifting from occupancy gains to pricing power (RevPAR). The company notes that differentiated, premium products in affluent locations command significant pricing power, which is becoming the key differentiator as the market matures.
- Operational Efficiency & Technology: The WellTower Business System (WBS) is central to improving efficiency. Expense growth (OpEx) remained well-contained at 4.3%, or just 0.8% on an export basis (adjusted for occupancy), allowing for substantial margin expansion. WBS enables granular cost optimization and enhances the resident/employee experience.
- Capital Allocation Discipline: Management emphasizes being "opportunity constrained" rather than capital constrained. They executed 196 granular transactions totaling $21 billion YTD, rejecting over 97% of screened deals due to strict criteria regarding price, location, and product-market fit. This selective approach ensures high-quality assets with clear paths for cash flow compounding.
- Balance Sheet Strength: The balance sheet remains exceptionally low-leveraged (Net Debt/Adjusted EBITDA ~3.02x) with strong liquidity ($2.4B cash on hand). This flexibility allows the company to capitalize on opportunities when financing markets are volatile and sellers prioritize execution certainty over highest paper bids.
- Genesis Healthcare Lessons: The successful restructuring and repayment of loans from Genesis Healthcare provided critical lessons in skilled nursing. Management learned to underwrite operators rather than just buildings, structure for downside risks, and overcome biases against the sector through rigorous data analysis and operational engagement.
Segment performance
Senior Housing Operating Portfolio (SHOP): Delivered strong performance with 9.1% organic revenue growth, driven by a 320 basis point occupancy gain and 5.3% RevPAR growth. Same-store NOI increased by 21% year-over-year, with an operating margin of 31.7% (up 310 bps) and a record flow-through margin of 66%. SHOP now represents approximately 70% of total same-store NOI.
Senior Housing Triple Net Portfolio: Same-store NOI grew 4.2% year-over-year, with trailing 12-month EBITDA coverage at 1.22x.
Skilled Nursing Portfolio: Same-store NOI grew 2.8% year-over-year, with trailing 12-month EBITDA coverage at 1.32x.
Total Portfolio: Total same-store NOI increased 15.8% year-over-year.
Guidance
- Full Year 2026 Normalized FFO per diluted share guidance raised to $6.47–$6.53, with a midpoint of $6.50 (an increase of $0.10 from prior guidance).
- Full Year 2026 Net Income attributable to common stockholders updated to $3.31–$3.37 per diluted share.
- The FFO revision reflects +$0.03 from Senior Housing Operating NOI, +$0.05 from investment/financing activity, and a 1.5% benefit from FX/taxes, partially offset by higher G&A.
- Assumes total portfolio same-store NOI growth of 15.0%–16.25% YoY, driven by SHOP growth of 20.25%–21.75%.
Risks
- Macroeconomic Volatility: Rising interest rates (30-year Treasury >5.3%) and geopolitical tensions (Middle East conflicts impacting oil prices) create a challenging financing environment, particularly for owners of maturing debt in 2026-2028.
- Private Credit Stress: Private credit defaults are running near 6%, and CMBS delinquencies have climbed above 8%, increasing systemic risk and potential distress among asset owners.
- Execution Risk: Success depends heavily on post-closing operational execution by partners. Differences in operator acumen can lead to wide variances in performance (2% vs. 20% growth).
- Supply Chain & Labor: While currently contained, wage growth and labor availability remain potential headwinds, though WBS initiatives aim to mitigate these through efficiency gains.
Q&A highlights
Q: Why does Welltower win competitive bidding processes despite executing only <3% of screened deals?
A: Nikhil Chaudhri attributed success to reputation, speed, and execution certainty. Sellers value the ability to close at agreed prices without retrades. The company’s granular data science platform allows for precise underwriting of neighborhood-level assets, ensuring they pay fair value while guaranteeing transaction integrity. B: What is the binding constraint to compound cash flow over the next five years?
A: Shankh Mitra stated that capital is not a constraint; the company is "opportunity constrained." Future growth depends entirely on executing within the existing portfolio via the WellTower Business System (WBS) and maintaining premium product-market fit, rather than acquiring new assets. C: How will the transition from occupancy-driven to pricing-driven growth impact margins?
A: Management highlighted that pricing generates superior flow-through margins compared to occupancy because incremental revenue from rate increases carries minimal associated costs. As occupancy exceeds 90%, this shift is expected to drive further margin expansion, with communities above 90% seeing RevPAR growth above 6%. D: What lessons were learned from the Genesis Healthcare bankruptcy?
A: Management noted that initial bias viewed skilled nursing as a "bad business," but deep engagement revealed it was an execution problem. Key lessons include underwriting operators over buildings, structuring for downside protection, and using data to challenge preconceived notions about sector viability. E: Are there concerns about new luxury supply limiting future pricing power?
A: Shankh Mitra argued that new development is unlikely to materialize quickly in prime locations like Cupertino due to long construction timelines and zoning hurdles. Therefore, oversupply risk in these specific micro-markets is considered improbable, preserving pricing power for established premium assets.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | $0.54 | $0.64 | -15.8% | — |
| Revenue | $3.72B | $3.64B | +2.0% | — |
Transcript
October 27, 2026Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.